Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Kirk

Showing results (51-60 of 171) with videos related to

Pageof 18
Sort By:
Journal of the International AIDS Society|November 15, 2014
Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failureAnna Schultze, Roger Paredes, Caroline Sabin, et al.
AIDS (London, England)|June 5, 2010
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patientsAmanda Mocroft, Ole Kirk, Peter Reiss, et al.
AIDS (London, England)|October 4, 2008
Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort studyAlessandro Cozzi-Lepri, Andrew N Phillips, Bonaventura Clotet, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 18, 2003
Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisitedAntonia L Moore, Ole Kirk, Anne M Johnson, et al.
AIDS (London, England)|January 29, 2014
Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosisDaniel Grint, Lars Peters, Juergen K Rockstroh, et al.
Cancer|June 16, 2004
The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA StudyAmanda Mocroft, Ole Kirk, Nathan Clumeck, et al.
Plos One|February 6, 2014
Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in EuropeAlexander Zoufaly, Alessandro Cozzi-Lepri, Joanne Reekie, et al.
Antiviral Therapy|July 1, 2010
Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapyAmanda Mocroft, Andrew N Phillips, Bruno Ledergerber, et al.
AIDS (London, England)|May 26, 2011
Tuberculosis among HIV-positive patients across Europe: changes over time and risk factorsAlexey Kruk, Wendy Bannister, Daria N Podlekareva, et al.
The Journal of Infectious Diseases|June 25, 2025
Risk of cancer after tuberculosis disease among people with HIV in Denmark: a nationwide population-based cohort studyChristian Kraef, Lars Haukali Omland, Anders Porskrog, et al.
Pageof 18

Showing results (51-60 of 171) with videos related to

Sort By:
Pageof 18
Journal of the International AIDS Society|November 15, 2014
Detection of resistance mutations and CD4 slopes in individuals experiencing sustained virological failureAnna Schultze, Roger Paredes, Caroline Sabin, et al.
AIDS (London, England)|June 5, 2010
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patientsAmanda Mocroft, Ole Kirk, Peter Reiss, et al.
AIDS (London, England)|October 4, 2008
Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort studyAlessandro Cozzi-Lepri, Andrew N Phillips, Bonaventura Clotet, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 18, 2003
Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisitedAntonia L Moore, Ole Kirk, Anne M Johnson, et al.
AIDS (London, England)|January 29, 2014
Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosisDaniel Grint, Lars Peters, Juergen K Rockstroh, et al.
Cancer|June 16, 2004
The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA StudyAmanda Mocroft, Ole Kirk, Nathan Clumeck, et al.
Plos One|February 6, 2014
Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in EuropeAlexander Zoufaly, Alessandro Cozzi-Lepri, Joanne Reekie, et al.
Antiviral Therapy|July 1, 2010
Estimated average annual rate of change of CD4(+) T-cell counts in patients on combination antiretroviral therapyAmanda Mocroft, Andrew N Phillips, Bruno Ledergerber, et al.
AIDS (London, England)|May 26, 2011
Tuberculosis among HIV-positive patients across Europe: changes over time and risk factorsAlexey Kruk, Wendy Bannister, Daria N Podlekareva, et al.
The Journal of Infectious Diseases|June 25, 2025
Risk of cancer after tuberculosis disease among people with HIV in Denmark: a nationwide population-based cohort studyChristian Kraef, Lars Haukali Omland, Anders Porskrog, et al.
Pageof 18